Navigation Links
Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Date:8/14/2008

une 30

2008 2007 2008 2007

As Adjusted As Adjusted

(Note1) (Note 1)

REVENUE - RELATED

PARTIES $ 19,654,447 $ 14,320,482 $ 32,475,268 $30,557,271

COST OF SALES -

RELATED PARTIES 6,203,705 4,454,594 10,243,765 8,890,193

GROSS PROFIT 13,450,742 9,865,888 22,231,503 21,667,078

SELLING, GENERAL AND

ADMINISTRATIVE

EXPENSES 5,088,597 3,388,675 8,335,796 6,653,582

INCOME FROM

OPERATIONS 8,362,145 6,477,213 13,895,707 15,013,496

(Interest

expense) (80,078) (106,351) (132,662) (211,573)

Interest income 268,517 587,270 505,849 1,217,183

Other (expense), net (1,246,287) (42,984) (986,864) (117,463)

OTHER (EXPENSE),

INCOME, NET (1,057,848) 437,935 (613,677) 888,147

INCOME BEFORE

PROVISION FOR INCOME

TAXES AND MINORITY

INTEREST 7,304,297 6,915,148 13,282,030 15,901,643

PROVISION FOR

INCOME TAXES 1,664,054 555,395 3,144,448 1,266,405

INCOME BEFORE

MINORITY INTEREST 5,640,243 6,359,753 10,137,582 14,635,238

MINORITY INTEREST 998,642 1,369,361 1,887,079 3,122,579

NET INCOME 4,641,601 4,990,392 8,250,503 11,512,659

OTHER COMPREHENSIVE

INCOME

Foreign currency

translation

adjustment 2,675,768 2,383,905 7,099,628 3,773,257

COMPREHENSIVE

INCOME $ 7,317,369 $ 7,374,297 $ 15,350,131 $15,285,916

EARNINGS PER SHARE,

BASIC AND DILUTED $ 0.07 $ 0.07 $ 0.12 $ 0.16

'/>"/>
SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. eFuture Signs Contract to Provide Tiens Group with Retail Business Management System
2. Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results
3. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
4. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. ThirdBiotech Announces Kemeta as Newest Sponsor
7. Yongye Biotechnology International Retains CCG Investor Relations
8. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
9. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
10. Ortho Biotech Announces Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot Number P114942A
11. New Book on the Business of Biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 DTS ... to its Online Web Portal for Life Science organizations who ... to specify the subject matter of their documents in advance ... will help reduce time-to-delivery of translations, often a critical factor ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 Date: ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, Warrington, ... only national nonprofit organization solely dedicated to finding a cure ... those affected worldwide, will host its annual Crystal Ball on ...
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, ... is an emerging biomedical company acquiring, developing, manufacturing, and ... , Free report download: http://equitiesiq.com/reports/alliqua/ , In ... team and Board, which launched the company’s new strategy ...
(Date:1/14/2014)... , Jan. 14, 2014  RXi Pharmaceuticals Corporation ... developing and commercializing innovative therapies addressing major unmet ... it received the Notice of Allowance from the ... unique self-delivering RNAi compounds (sd-rxRNA®), for the treatment ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... DETROIT, Oct. 23 Caraco Pharmaceutical,Laboratories, Ltd. (Amex: ... and,first six months of Fiscal 2009 of $122.2 million ... $76.8 million, respectively,for the corresponding periods of Fiscal 2008. ... periods of Fiscal 2008. Pre-tax income,grew to $12.3 million ...
... MIAMI, Oct. 23 NOVIS Pharmaceuticals, Inc. today,announced ... been,appointed Chairman of the Board. The appointment was ... meeting and is effective immediately., (Logo: ... to take on this role at NOVIS, and ...
... Ltd (BioWisdom),the market leader in delivering healthcare ... release of OmniViz,Visualization Software for Patent Specialists., ... in competitive business and,technical intelligence analyses to ... can turn the analysis of thousands of,patents ...
Cached Biology Technology:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009 7Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009 8NOVIS Announces Appointment of John J. Arlotta as Chairman 2
(Date:4/17/2014)... study suggests that fish consumption advisories for expecting ... long-lived contaminants like persistent organic pollutants (POPs). ... researchers including University of Toronto Scarborough PhD student ... how different levels of environmental contamination, a mother,s ... in the body influenced exposure in her children. ...
(Date:4/17/2014)... release is available in German . ... to recognise objects; they also provide us with a continuous ... turn around, fall or sit still in a car ... trace on our retinas. Seemingly without effort, our brain calculates ... a stable position and a steady gaze during our own ...
(Date:4/17/2014)... The White House honored Clemson professor Rajendra Singh ... efforts to promote and expand solar deployment in ... the D. Houser Banks Professor of Electrical and ... Silicon Nanoelectronics, is considered a local hero leading ... and economic opportunity in solar power and driving ...
Breaking Biology News(10 mins):Fish consumption advisories fail to cover all types of contaminants 2How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4White House honors Clemson professor as 'Champion of Change' for solar deployment 2
... PARK, Maryland A University of Maryland-led team of ... the impacts of climate change could affect civil conflicts. ... between conflict, socio-economic conditions and climate. They will use ... The U.S. Department of Defense is funding the ...
... rid of excess energy through the production of hydrogen. Biologists at ... absence of oxygen. For this, they need the messenger molecule nitric ... blood cells of humans. With colleagues at the UC Los Angeles, ... Haemoglobin an old protein in a new look ...
... into the human genome more readily in tumors than ... from the University of Maryland School of Medicine,s Institute ... from the Human Genome Project, the 1,000 Genomes Project ... phenomenon of lateral gene transfer (LGT), the transmission of ...
Cached Biology News:DoD-funded research: Can climate change heat up conflict? 2When green algae run out of air 2Bacterial DNA may integrate into human genome more readily in tumor tissue 2
DNase I (Deoxyribonuclease I) digests single- and double-stranded DNA to oligodeoxyribonucleotides. Ribonuclease activity has been reduced to non-detectable levels....
... strain containing an overproducing clone of M-MLV ... catalyzes the polymerization of DNA using template ... of large mRNAs, >10 kb, may be ... lower RNase H activity than AMV Reverse ...
... DNase is a preparation of deoxyribonuclease ... DNA to produce 3-hydroxyl oligonucleotides. This ... applications where maintaining the integrity of ... qualified for use with the Core ...
...
Biology Products: